MCID: APH001
MIFTS: 62

Aphthous Stomatitis malady

Categories: Rare diseases, Oral diseases

Aliases & Classifications for Aphthous Stomatitis

Aliases & Descriptions for Aphthous Stomatitis:

Name: Aphthous Stomatitis 12 50 14 69
Oral Ulcer 12 29 52 69
Minor Oral Aphthous Ulceration 69
Stomatitis, Aphthous 42
Aphthous Ulceration 12
Oral Aphthous Ulcer 12
Oral Aphthae 12
Canker Sores 41
Canker Sore 12
Aphtha 12

Classifications:



Summaries for Aphthous Stomatitis

MedlinePlus : 41 canker sores are small, round sores in your mouth. they can be on the inside of your cheek, under your tongue, or in the back of your throat. they usually have a red edge and a gray center. they can be quite painful. they are not the same as cold sores, which are caused by herpes simplex. canker sores aren't contagious. they may happen if you have a viral infection. they may also be triggered by stress, food allergies, lack of vitamins and minerals, hormonal changes or menstrual periods. in some cases the cause is unknown. in most cases, the sores go away by themselves. some ointments, creams or rinses may help with the pain. avoiding hot, spicy food while you have a canker sore also helps.

MalaCards based summary : Aphthous Stomatitis, also known as oral ulcer, is related to celiac disease and burns, and has symptoms including halitosis, snoring and enanthema. An important gene associated with Aphthous Stomatitis is MEFV (MEFV, Pyrin Innate Immunity Regulator), and among its related pathways/superpathways are Innate Immune System and Cytokine Signaling in Immune system. The drugs Dexamethasone and Mifepristone have been mentioned in the context of this disorder. Affiliated tissues include tongue, testes and neutrophil, and related phenotypes are hematopoietic system and immune system

Disease Ontology : 12 A stomatitis characterized by the repeated formation of benign and non-contagious mouth ulcers.

Wikipedia : 71 Aphthous stomatitis is a common condition characterized by the repeated formation of benign and... more...

Related Diseases for Aphthous Stomatitis

Diseases related to Aphthous Stomatitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 299)
id Related Disease Score Top Affiliating Genes
1 celiac disease 30.3 HLA-B IL1RN TNF
2 burns 30.0 IL10 IL6 TNF
3 pyoderma gangrenosum 29.9 IL1B IL6 TNF
4 hepatitis 29.3 HLA-A HLA-B IL10 IL6 TNF
5 rheumatoid arthritis 29.3 IL10 IL1B IL1RN IL4 IL6 TNF
6 periodic fever, aphthous stomatitis, pharyngitis and adenitis 12.5
7 sutton disease 2 11.8
8 stomatitis 11.2
9 ulcerative stomatitis 11.1
10 pharyngitis 10.7
11 cervicitis 10.6
12 cervical adenitis 10.5
13 intussusception 10.3 IL1B TNF
14 vps11-related autosomal recessive hypomyelinating leukodystrophy 10.3 IL6 TNF
15 pyridoxal 5'-phosphate-dependent epilepsy 10.3 IL10 TNF
16 dyslexia 5 10.3 IL6 TNF
17 aortic atherosclerosis 10.3 IL6 TNF
18 oculomotor nerve paralysis 10.3 IL1B IL6
19 common peroneal nerve lesion 10.3 IL1B IL6
20 degenerative disc disease 10.3 IL6 TNF
21 stocco dos santos syndrome 10.3 IL1B TNF
22 myeloid neoplasms associated with pdgfrb rearrangement 10.3 MEFV TNF
23 candidiasis, familial, 4, autosomal recessive 10.3 MEFV TNF
24 multiple vertebral anomalies unusual facies 10.3 IL10 TNF
25 mucositis 10.3
26 ureter inverted papilloma 10.3 IL10 IL6
27 unilateral multicystic dysplastic kidney 10.3 IL6 TNF
28 hypotrichosis-lymphedema-telangiectasia-renal defect syndrome 10.3 IL1B TNF
29 twin-to-twin transfusion syndrome 10.2 IL1B TNF
30 asymptomatic neurosyphilis 10.2 IL10 IL4
31 autosomal dominant deafness-onychodystrophy syndrome 10.2 IL4 TNF
32 thymic neuroendocrine carcinoma 10.2 IL6 TNF
33 anal paget's disease 10.2 IL1B IL6 TNF
34 bipolar i disorder 10.2 IL1B IL6 TNF
35 human immunodeficiency virus infectious disease 10.2 IL1B IL6 TNF
36 tinea capitis 10.2 IL1B IL6 TNF
37 measles 10.2 IL1B IL6 TNF
38 steroid dehydrogenase deficiency dental anomalies 10.2 IL1B IL6 TNF
39 ceroid lipofuscinosis, neuronal, 3 10.2 IL10 IL4
40 neonatal hypoxic and ischemic brain injury 10.2 IL10 IL6
41 acquired thrombocytopenia 10.2 IL1B IL6 TNF
42 transient tic disorder 10.2 IL10 IL6 TNF
43 mineral metabolism disease 10.2 IL1B IL6 TNF
44 migraine with aura 10.2 IL1B IL6 TNF
45 neuropathy 10.2 IL1B IL6 TNF
46 splenic artery aneurysm 10.2 IL1B IL6 TNF
47 ileocolitis 10.2 IL1B IL4
48 trichomalacia 10.2 IL10 IL6 TNF
49 phlyctenulosis 10.2 IL10 IL6 TNF
50 conduct disorder 10.2 IL10 IL6 TNF

Graphical network of the top 20 diseases related to Aphthous Stomatitis:



Diseases related to Aphthous Stomatitis

Symptoms & Phenotypes for Aphthous Stomatitis

UMLS symptoms related to Aphthous Stomatitis:


halitosis, snoring, enanthema, oral manifestations, oral mucosal blisters, sore mouth

MGI Mouse Phenotypes related to Aphthous Stomatitis:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 9.97 IL10 IL1B IL1RN IL4 IL6 MEFV
2 immune system MP:0005387 9.92 IL10 IL1B IL1RN IL4 IL6 MEFV
3 integument MP:0010771 9.86 IL10 IL1B IL1RN IL4 IL6 MEFV
4 liver/biliary system MP:0005370 9.63 IL10 IL4 IL6 MEFV NLRP3 TNF
5 reproductive system MP:0005389 9.5 NLRP3 TNF IL10 IL1RN IL4 IL6
6 skeleton MP:0005390 9.23 IL10 IL1B IL1RN IL4 IL6 MEFV

Drugs & Therapeutics for Aphthous Stomatitis

Drugs for Aphthous Stomatitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 783)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-02-2 5743
2
Mifepristone Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 84371-65-3 55245
3
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-78-2 2244
4
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 50-28-2 5757 53477783
5
Colchicine Approved Phase 4,Phase 3,Phase 2 64-86-8 6167 2833
6
Midazolam Approved, Illicit Phase 4,Phase 3,Phase 2,Phase 1 59467-70-8 4192
7
Pantoprazole Approved Phase 4,Phase 3,Phase 2,Phase 1 102625-70-7 4679
8
Diclofenac Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 15307-86-5 3033
9
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 73590-58-6 4594
10
Morphine Approved, Investigational Phase 4,Phase 3 57-27-2 5288826
11
Cimetidine Approved Phase 4,Phase 2,Phase 1 51481-61-9 2756
12
Acetaminophen Approved Phase 4,Phase 3,Phase 1,Phase 2 103-90-2 1983
13
Celecoxib Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 169590-42-5 2662
14
Ibuprofen Approved Phase 4,Phase 3,Phase 2 15687-27-1 3672
15
Histamine Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 75614-87-8, 51-45-6 774
16
Ticlopidine Approved Phase 4,Phase 1 55142-85-3 5472
17
Misoprostol Approved Phase 4,Phase 3,Phase 2,Phase 1 59122-46-2 5282381
18
Famotidine Approved Phase 4,Phase 2,Phase 3,Phase 1 76824-35-6 3325
19
Bosentan Approved, Investigational Phase 4,Phase 3,Phase 2 147536-97-8 104865
20
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2 50-24-8 5755
21
Norgestimate Approved Phase 4,Phase 3,Phase 2 35189-28-7 6540478
22
Oxytocin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-56-6 439302 53477758
23
Clarithromycin Approved Phase 4,Phase 3,Phase 2,Phase 1 81103-11-9 84029
24
Tranexamic Acid Approved Phase 4 1197-18-8 5526
25
Amoxicillin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 26787-78-0 33613 2171
26
Doxycycline Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 564-25-0 54671203
27
Metronidazole Approved Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1 443-48-1 4173
28
Sucralfate Approved Phase 4,Phase 3 54182-58-0
29
Moxifloxacin Approved, Investigational Phase 4,Phase 3,Phase 2 354812-41-2, 151096-09-2 152946
30
Lansoprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 103577-45-3 3883
31
Rabeprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 117976-89-3 5029
32
Esomeprazole Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 161796-78-7, 119141-88-7 4594 9579578
33
Vildagliptin Approved, Investigational Phase 4 274901-16-5 6918537
34
Benzocaine Approved Phase 4,Phase 3,Phase 2 1994-09-7, 94-09-7 2337
35
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2 83-43-2 6741
36
Ethinyl Estradiol Approved Phase 4,Phase 3,Phase 2 57-63-6 5991
37
Alprostadil Approved, Investigational Phase 4,Phase 3,Phase 2 745-65-3 149351
38
Dinoprostone Approved Phase 4,Phase 3 363-24-6 5280360
39
Heparin Approved, Investigational Phase 4 9005-49-6 772 46507594
40
Dopamine Approved Phase 4,Phase 3,Phase 1 51-61-6, 62-31-7 681
41
Gabapentin Approved, Investigational Phase 4 60142-96-3 3446
42
Zinc Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 7440-66-6 32051 23994
43
Cyclosporine Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 79217-60-0, 59865-13-3 5284373 6435893
44
Progesterone Approved, Vet_approved Phase 4 57-83-0 5994
45
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 2 104987-11-3 445643 439492
46
Ritonavir Approved, Investigational Phase 4,Phase 1 155213-67-5 392622
47
Methotrexate Approved Phase 4,Phase 2,Phase 1 1959-05-2, 59-05-2 126941
48
Ketoconazole Approved, Investigational Phase 4,Phase 1 65277-42-1 47576 3823
49
Iron Approved Phase 4,Phase 3,Phase 2 7439-89-6 23925
50
Tenofovir Approved, Investigational Phase 4,Phase 1 147127-20-6 464205

Interventional clinical trials:

(show top 50) (show all 1092)
id Name Status NCT ID Phase
1 Long-term Oral Esomeprazole for Prevention of Peptic Ulcer Rebleeding in High-risk Patients Unknown status NCT02456012 Phase 4
2 Oral vs Intravenous and Proton Pump Inhibitor (PPI)for Peptic Ulcer Bleeding (PUB) Unknown status NCT01123031 Phase 4
3 Compare Efficacy of Gastric Acid Suppression by Oral and Intravenous Administration of Esomeprazole in Patients With Peptic Ulcer Unknown status NCT00471029 Phase 4
4 Outcomes of Non-infected Diabetic Foot Ulcers With/Without Antibiotics Unknown status NCT01418456 Phase 4
5 ZeroTolerance Mucositis: Managing Oral and Alimentary Mucositis With High Potency Sucralfate - ProThelial Unknown status NCT02016807 Phase 4
6 A Double Blind Study Comparing Two Doses of IV Esomeprazole After Successful Endoscopic Therapy Unknown status NCT01275937 Phase 4
7 Role of Healthy Bacteria in Ulcerative Colitis Unknown status NCT01479660 Phase 4
8 Does Early Re-administration of Aspirin/Clopidogrel Increase the Risk of Bleeding From Artificial Ulcer After EMR or ESD? Unknown status NCT01621451 Phase 4
9 Helicobacter Pylori Empiric Treatment in Ulcer Bleeding Unknown status NCT00687336 Phase 4
10 The Clinical And Subclinical Effects on Arterial Stiffness of Bosentan in Patients With Systemic Sclerosis Unknown status NCT02480335 Phase 4
11 Comparison of Oral Rabeprazole vs. iv Omeprazole in Mild to Moderate Nonvariceal Upper Gastrointestinal Bleeding Unknown status NCT00861640 Phase 4
12 Efficacy and Safety Study of Titrated Oral Misoprostol Solution for Labor Augmentation Unknown status NCT00695331 Phase 4
13 Dexlansoprazole to Treat Laryngopharyngeal Reflux and Lingual Tonsil Hypertrophy Unknown status NCT01328652 Phase 4
14 Esomeprazole Plus Alginate vs. Esomeprazole Alone for Treatment of Nighttime Reflux Symptom and Sleep Disturbances Unknown status NCT02277886 Phase 4
15 The Effects of Reducing Stomach Acid on Post-Tonsillectomy Pain Unknown status NCT00472186 Phase 4
16 The Relationship Between Gastroesophageal Reflux and Pediatric Rhinitis: Significance of Pale/Blue Colored Turbinate Unknown status NCT02278081 Phase 4
17 The Efficacy of Pantoprazole Treatment in Patients With Functional Dyspepsia Unknown status NCT01608750 Phase 4
18 The Efficacy of Double Doses of Oral Esomeprazole in Preventing Rebleeding for Patients With Bleeding Peptic Ulcers Completed NCT01591083 Phase 4
19 Effects of Oral Rabeprazole on the Prevention of Ulcer Bleeding Following Endoscopic Mucosal Resection Completed NCT00844675 Phase 4
20 A Clinical Trial to Study the Effects of Two Drugs, Lycopene and Prednisolone in Patients With Oral Lichen Planus Completed NCT02587117 Phase 4
21 Prevention of Gastrointestinal Bleeding in Patients With Severe Ischemic Heart Disease Completed NCT00683111 Phase 4
22 Argon Plasma Coagulation for Bleeding Peptic Ulcers Completed NCT02241044 Phase 4
23 Comparison of Esomeprazole and Famotidine for Stress Ulcer Prophylaxis in Neurosurgical Intensive Care Unit Completed NCT00633035 Phase 4
24 Study Comparing Cyclosporine With Infliximab in Steroid-refractory Severe Attacks of Ulcerative Colitis Completed NCT00542152 Phase 4
25 Different Dose of Intravenous Omeprazole to Treat Bleeding Ulcer With Adherent Clot Completed NCT02536989 Phase 4
26 Rectal Tacrolimus in the Treatment of Resistant Ulcerative Proctitis Completed NCT01418131 Phase 4
27 DPP IV Inhibition Facilitates Healing of Chronic Foot Ulcers in Type 2 Diabetes Completed NCT01472432 Phase 4
28 Comparison of the Efficacy for Stress Ulcer Prophylaxis Between the Patients Received Lansoprazole OD and Control Group Weaning From Mechanical Ventilator in Respiratory Care Center: a Randomized Control Trial Completed NCT00708149 Phase 4
29 Healing Effects of Rebamipide and Omeprazole in Helicobacter Pylori-positive Gastric Ulcer After Eradication Therapy Completed NCT00272467 Phase 4
30 Importance of Cytokines in Peptic Ulcer Disease: Implications for Treatment Completed NCT00534443 Phase 4
31 The Therapeutic Role of Intravenous Albumin Administration for Peptic Ulcer Bleeding Patients With Hypoalbuminemia Completed NCT01822600 Phase 4
32 Tolerability, Efficacy and Mucosal Inflammation Associated With Orally Administered Colon Cleansing for Colonoscopy Completed NCT00750763 Phase 4
33 Treatment of Iron Deficiency Anaemia in Inflammatory Bowel Disease With Ferrous Sulphate Completed NCT01991314 Phase 4
34 Topical Morphine for Stomatitis-related Pain Induced by Chemotherapy Completed NCT00357942 Phase 4
35 Use Of Esomeprazole In Postoperative Bariatric Surgery Patients Users And Non-Users Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDS) Completed NCT00608712 Phase 4
36 Combined Therapy in Radiation Proctopathy Completed NCT01613534 Phase 4
37 A Trial of Iron Replacement in Patients With Iron Deficiency. Completed NCT01067547 Phase 4
38 Strategies in Maintenance for Patients Receiving Long-term Therapy (S.I.M.P.L.E.) With MMX (Multi-Matrix System) Mesalamine for Ulcerative Colitis (UC) Completed NCT00446849 Phase 4
39 Colchicine Or Naproxen Treatment for ACute gouT Completed NCT01994226 Phase 4
40 Study of Intragastric pH Profile After 5 Days Pantoprazole 40 mg iv Followed by Oral Esomeprazole 40 mg po or Oral Pantoprazole 40 mg po Completed NCT00206050 Phase 4
41 Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Bismuth-containing Quadruple Therapy Completed NCT02296021 Phase 4
42 Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Clarithromycin Quadruple Therapy Completed NCT02633930 Phase 4
43 Open, Randomized, Two Way Crossover Study Comparing the Effect of Esomeprazole Adminstered Orally and iv Completed NCT00626262 Phase 4
44 Study Comparing the Effects of Esomeprazole Adminstered Orally and Intravenously on Basal and Pentrigastrin-stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD) Completed NCT00625495 Phase 4
45 A Bioequivalence Study of Idiazole 20mg DR Tabs and PARIET® 20 mg DR Tabs After a Single Oral Dose Administration Under Fasting Conditions in Healthy Adults Completed NCT02446483 Phase 4
46 An Open, Randomized, Two Way Crossover Study Comparing the Effect of 20mg Esomeprazole Administered Orally and Intravenously as a 15 Minute Infusion on Basal and Pentagastrin-Stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Dise Completed NCT00629564 Phase 4
47 Open, Randomized, Two Way Crossover 40mg, Orally and Intravenously Completed NCT00635414 Phase 4
48 Symptomatic Relief of Acute Dyspeptic Pain in Emergency Department With Pantoprazole Completed NCT01281501 Phase 4
49 NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis Completed NCT00206180 Phase 4
50 An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD) Completed NCT00242736 Phase 4

Search NIH Clinical Center for Aphthous Stomatitis

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: stomatitis, aphthous

Genetic Tests for Aphthous Stomatitis

Genetic tests related to Aphthous Stomatitis:

id Genetic test Affiliating Genes
1 Oral Ulcer 29

Anatomical Context for Aphthous Stomatitis

MalaCards organs/tissues related to Aphthous Stomatitis:

39
Tongue, Testes, Neutrophil, T Cells, Heart, Monocytes, Thyroid

Publications for Aphthous Stomatitis

Articles related to Aphthous Stomatitis:

(show top 50) (show all 577)
id Title Authors Year
1
Enzymatic antioxidants status in patients with recurrent aphthous stomatitis. ( 28054386 )
2017
2
Antigastric parietal cell and antithyroid autoantibodies in patients with recurrent aphthous stomatitis. ( 27793414 )
2017
3
Investigation of CD40 gene rs4810485 and rs1883832 mutations in patients with recurrent aphthous stomatitis. ( 27875792 )
2017
4
Efficacy and safety of Chinese patent medicines in the treatment ofA recurrent aphthous stomatitis: A systematic review. ( 28062049 )
2017
5
Aphthous stomatitis. ( 27742082 )
2016
6
Tonsillar microbiota in children with PFAPA (periodic fever, aphthous stomatitis, pharyngitis, and adenitis) syndrome. ( 27025724 )
2016
7
Association between serotonin transporter gene polymorphism and recurrent aphthous stomatitis. ( 27274339 )
2016
8
Guidelines for the management and treatment of periodic fever syndromes: periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome. ( 27267334 )
2016
9
Efficacy of alum for treatment of recurrent aphthous stomatitis. ( 27757206 )
2016
10
Comment on "The relationship of recurrent aphthous stomatitis and Helicobacter pylori, cytokine gene polymorphism and cobalamin". ( 26620964 )
2016
11
Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) syndrome: analysis of patients from two geographic areas. ( 27059542 )
2016
12
HLA-DRB and HLA-DQB Allele and Haplotype Frequencies in Iranian Patients with Recurrent Aphthous Stomatitis. ( 27921409 )
2016
13
Long-Term Outcome of Classic and Incomplete PFAPA (Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenitis) Syndrome after Tonsillectomy. ( 27692464 )
2016
14
Total antioxidant status and oxidative stress in recurrent aphthous stomatitis. ( 26625952 )
2016
15
Investigation of BehAset's Disease and Recurrent Aphthous Stomatitis Frequency: The Highest Prevalence in Turkey. ( 27606133 )
2016
16
The safety and efficacy of AphtoFixAr mouth ulcer cream in the management of recurrent aphthous stomatitis. ( 26868504 )
2016
17
Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome: a Review of the Pathogenesis. ( 26984802 )
2016
18
Is there a role of food additives in recurrent aphthous stomatitis? A prospective study with patch testing. ( 28035659 )
2016
19
Status of Neutrophils, Lymphocytes and Platelets in Patients with Recurrent Aphthous Stomatitis: A Retrospective Study. ( 28008393 )
2016
20
Effectiveness of Laser Therapy in the Management of Recurrent Aphthous Stomatitis: A Systematic Review. ( 28078164 )
2016
21
Hematinic deficiencies and anemia statuses in recurrent aphthous stomatitis patients with or without atrophic glossitis. ( 27839675 )
2016
22
A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome. ( 27251674 )
2016
23
Quality of life in patients with recurrent aphthous stomatitis treated with a mucoadhesive patch containing citrus essential oil. ( 27313450 )
2016
24
Recurrent aphthous stomatitis and Helicobacter pylori. ( 26827061 )
2016
25
Efficacy and safety of topical herbal medicine treatment on recurrent aphthous stomatitis: a systemic review. ( 26770058 )
2016
26
Clinical phenotype of recurrent aphthous stomatitis and interleukin-1I^ genotype in a Polish cohort of patients. ( 27935125 )
2016
27
Review of autoinflammatory diseases, with a special focus on periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome. ( 27426283 )
2016
28
Lack of Association between Interleukin-12 Gene Polymorphisms and Recurrent Aphthous Stomatitis. ( 27920889 )
2016
29
Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome. ( 27343963 )
2016
30
Efficacy of Omega-3 in Treatment of Recurrent Aphthous Stomatitis: A Randomised, Double-blind, Placebo-controlled Study. ( 27622219 )
2016
31
Is Optimal Management of Recurrent Aphthous Stomatitis Possible? A Reality Check. ( 27891490 )
2016
32
Salivary oxidant/ antioxidant status and hematological parameters in patients with recurrent aphthous stomatitis. ( 26958327 )
2016
33
Ozone treatment of recurrent aphthous stomatitis: a double blinded study. ( 27301301 )
2016
34
Mucosal and salivary microbiota associated with recurrent aphthous stomatitis. ( 27036492 )
2016
35
Recurrent Aphthous Stomatitis As a Marker of Celiac Disease in Children. ( 27001329 )
2016
36
Response to "Recurrent Aphthous Stomatitis As a Marker of Celiac Disease in Children". ( 26857100 )
2016
37
Family History in Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis (PFAPA) Syndrome. ( 27565549 )
2016
38
Clinical efficacy of a solution composed by sodium bicarbonate and alginate, aloe vera, propoli, chamomile, calendula and honey, in the treatment of minor recurrent aphthous stomatitis in children. ( 27768020 )
2016
39
A comparison of the effect of triamcinolone ointment and mouthwash with or without zinc on the healing process of aphthous stomatitis lesions. ( 27429724 )
2016
40
Anemia and hematinic deficiencies in anti-gastric parietal cell antibody-positive or all autoantibodies-negative recurrent aphthous stomatitis patients. ( 27825815 )
2016
41
Different modalities for treatment of recurrent aphthous stomatitis. A Randomized clinical trial. ( 27957263 )
2016
42
Recurrent aphthous stomatitis. ( 27343962 )
2016
43
Effects of colchicine treatment on mean platelet volume and the inflammatory markers in recurrent aphthous stomatitis. ( 26943669 )
2016
44
The relationship between recurrent aphthous stomatitis, and periodontal disease and Helicobacter Pylori infection. ( 26733449 )
2016
45
Hypofunction of the Sympathetic Nervous System as a Possible Etiologic Cause of Recurrent Aphthous Stomatitis. ( 27517475 )
2016
46
Design, Formulation and Evaluation of an Oral Gel from Punica Granatum Flower Extract for the Treatment of Recurrent Aphthous Stomatitis. ( 27766223 )
2016
47
Anemia and hematinic deficiencies in anti-gastric parietal cell antibody-positive and -negative recurrent aphthous stomatitis patients with anti-thyroid antibody positivity. ( 27825814 )
2016
48
Effect of bedtime on recurrent aphthous stomatitis in college students. ( 25577415 )
2015
49
Colchicine as a therapeutic option in periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis (PFAPA) syndrome. ( 26315860 )
2015
50
Triamcinolone Acetonide Oromucoadhesive Paste for Treatment of Aphthous Stomatitis. ( 26236668 )
2015

Variations for Aphthous Stomatitis

Expression for Aphthous Stomatitis

Search GEO for disease gene expression data for Aphthous Stomatitis.

Pathways for Aphthous Stomatitis

Pathways related to Aphthous Stomatitis according to GeneCards Suite gene sharing:

(show top 50) (show all 55)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
13.91 HLA-A HLA-B IL10 IL1B IL1RN IL4
2
Show member pathways
13.24 HLA-A HLA-B IL10 IL1B IL1RN IL4
3
Show member pathways
12.95 IL1B IL1RN IL6 MEFV NLRP3 TNF
4
Show member pathways
12.65 HLA-A HLA-B IL10 IL1B IL4 IL6
5
Show member pathways
12.58 IL10 IL1B IL4 IL6 TNF
6
Show member pathways
12.56 HLA-A HLA-B IL1B IL4 IL6 NLRP3
7
Show member pathways
12.53 IL10 IL1B IL6 TNF
8 12.52 IL10 IL1B IL1RN IL4 TNF
9
Show member pathways
12.46 HLA-A HLA-B IL4 TNF
10
Show member pathways
12.4 IL10 IL1B IL4 IL6 TNF
11 12.39 HLA-A HLA-B IL6 TNF
12
Show member pathways
12.31 IL1B IL4 IL6 TNF
13
Show member pathways
12.31 IL1B IL4 IL6 TNF
14
Show member pathways
12.24 IL10 IL1B IL4 TNF
15 12.21 IL10 IL1B IL6 TNF
16
Show member pathways
12.18 IL1B IL6 TNF
17
Show member pathways
12.17 IL1B IL4 IL6 TNF
18
Show member pathways
12.13 IL10 IL4 IL6
19 12.12 IL10 IL1B IL1RN IL6 TNF
20